Visfatin (Nampt) and Ghrelin as Novel Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes - Kadoglou, N. P. E.; Sailer, N.; Moumtzouoglou, A.; Kapelouzou, A.; Tsanikidis, H.; Vitta, I.; Karkos, C.; Karayannacos, P. E.; Gerasimidis, T.; Liapis, C. D. (Experimental and Clinical Endocrinology & Diabetes, 2010)